Terms: = Germ cell tumor AND NDRG1, NDR1, 10397, ENSG00000104419, Q92597, RIT42, CMT4D, TARG1, HMSNL, GC4, RTP, TDD5, PROXY1, NMSL, CAP43 AND Treatment
22 results:
1. Clinical feasibility of a commercially available MRI-only method for radiotherapy treatment planning of the brain.
Ranta I; Wright P; Suilamo S; Kemppainen R; Schubert G; Kapanen M; Keyriläinen J
J Appl Clin Med Phys; 2023 Sep; 24(9):e14044. PubMed ID: 37345212
[TBL] [Abstract] [Full Text] [Related]
2. N-myc Downstream-Regulated Gene 1 (ndrg1) Regulates Vascular Endothelial Growth Factor A (VEGFA) and Malignancies in Glioblastoma Multiforme (GBM).
Zhang X; Chen Q; Li Y; Chen H; Jiang Q; Hu Q
Biomed Res Int; 2022; 2022():3233004. PubMed ID: 35813230
[TBL] [Abstract] [Full Text] [Related]
3. Iron-Chelation treatment by Novel Thiosemicarbazone Targets Major Signaling Pathways in Neuroblastoma.
Macsek P; Skoda J; Krchniakova M; Neradil J; Veselska R
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008802
[TBL] [Abstract] [Full Text] [Related]
4. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
Zhang J; Yang Y; Dong Y; Liu C
Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
[TBL] [Abstract] [Full Text] [Related]
5. Innovative therapies for neuroblastoma: The surprisingly potent role of iron chelation in up-regulating metastasis and tumor suppressors and down-regulating the key oncogene, N-myc.
Wijesinghe TP; Dharmasivam M; Dai CC; Richardson DR
Pharmacol Res; 2021 Nov; 173():105889. PubMed ID: 34536548
[TBL] [Abstract] [Full Text] [Related]
6. The Influence of ndrg1 Single Nucleotide Polymorphisms on Glioma Risk and Prognosis in Chinese Han Population.
Yang Y; Cheng Y; Yang L; Shi G; Chen P; Li L; Fang H; Chen C; Jin T
Cell Mol Neurobiol; 2022 Aug; 42(6):1949-1964. PubMed ID: 33709284
[TBL] [Abstract] [Full Text] [Related]
7. The Identification and Validation of a Robust Immune-Associated Gene Signature in Cutaneous Melanoma.
Song LB; Luan JC; Zhang QJ; Chen L; Wang HY; Cao XC; Song NH; Lu Y
J Immunol Res; 2021; 2021():6686284. PubMed ID: 33688507
[TBL] [Abstract] [Full Text] [Related]
8. SNAP reverses temozolomide resistance in human glioblastoma multiforme cells through down-regulation of MGMT.
Tsai CK; Huang LC; Wu YP; Kan IY; Hueng DY
FASEB J; 2019 Dec; 33(12):14171-14184. PubMed ID: 31725331
[TBL] [Abstract] [Full Text] [Related]
9. Bidirectional Regulation between ndrg1 and GSK3β Controls tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma.
Ito H; Watari K; Shibata T; Miyamoto T; Murakami Y; Nakahara Y; Izumi H; Wakimoto H; Kuwano M; Abe T; Ono M
Cancer Res; 2020 Jan; 80(2):234-248. PubMed ID: 31723002
[TBL] [Abstract] [Full Text] [Related]
10. Discovery of a novel rhein-SAHA hybrid as a multi-targeted anti-glioblastoma drug.
Chen J; Luo B; Wen S; Pi R
Invest New Drugs; 2020 Jun; 38(3):755-764. PubMed ID: 31414267
[TBL] [Abstract] [Full Text] [Related]
11. Technical feasibility of integrating 7 T anatomical MRI in image-guided radiotherapy of glioblastoma: a preparatory study.
Compter I; Peerlings J; Eekers DB; Postma AA; Ivanov D; Wiggins CJ; Kubben P; Küsters B; Wesseling P; Ackermans L; Schijns OE; Lambin P; Hoffmann AL
MAGMA; 2016 Jun; 29(3):591-603. PubMed ID: 27026245
[TBL] [Abstract] [Full Text] [Related]
12. ndrg1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment.
Broggini T; Wüstner M; Harms C; Stange L; Blaes J; Thomé C; Harms U; Mueller S; Weiler M; Wick W; Vajkoczy P; Czabanka M
Cancer Lett; 2016 Oct; 380(2):568-576. PubMed ID: 26297987
[TBL] [Abstract] [Full Text] [Related]
13. Overexpression of N-myc downstream-regulated gene 1 inhibits human glioma proliferation and invasion via phosphoinositide 3-kinase/AKT pathways.
Ma W; Na M; Tang C; Wang H; Lin Z
Mol Med Rep; 2015 Jul; 12(1):1050-8. PubMed ID: 25777142
[TBL] [Abstract] [Full Text] [Related]
14. The demonstration of extension of high-grade glioma beyond magnetic resonance imaging defined edema by the use of (11) C-methionine positron emission tomography.
Susheela SP; Revannasiddaiah S; Madhusudhan N; Bijjawara M
J Cancer Res Ther; 2013; 9(4):715-7. PubMed ID: 24518724
[TBL] [Abstract] [Full Text] [Related]
15. Global gene expression analysis reveals a link between ndrg1 and vesicle transport.
Askautrud HA; Gjernes E; Gunnes G; Sletten M; Ross DT; Børresen-Dale AL; Iversen N; Tranulis MA; Frengen E
PLoS One; 2014; 9(1):e87268. PubMed ID: 24498060
[TBL] [Abstract] [Full Text] [Related]
16. ndrg1 prognosticates the natural course of disease in WHO grade II glioma.
Blaes J; Weiler M; Sahm F; Hentschel B; Osswald M; Czabanka M; Thomé CM; Schliesser MG; Pusch S; Luger S; Winkler F; Radbruch A; Jugold M; Simon M; Steinbach JP; Schackert G; Tatagiba M; Westphal M; Tonn JC; Gramatzki D; Pietsch T; Hartmann C; Glimm H; Vajkoczy P; von Deimling A; Platten M; Weller M; Wick W
J Neurooncol; 2014 Mar; 117(1):25-32. PubMed ID: 24395351
[TBL] [Abstract] [Full Text] [Related]
17. Synthetic glycolipids for glioma growth inhibition developed from neurostatin and NF115 compound.
Doncel-Pérez E; García-Álvarez I; Fernández-Mayoralas A; Nieto-Sampedro M
Bioorg Med Chem Lett; 2013 Jan; 23(2):435-9. PubMed ID: 23245511
[TBL] [Abstract] [Full Text] [Related]
18. Transcriptome and coexpression network analysis of the human glioma cell line Hs683 exposed to candoxin.
Jiang YX; Ma Y; Cheng Y
J Int Med Res; 2012; 40(3):887-98. PubMed ID: 22906261
[TBL] [Abstract] [Full Text] [Related]
19. Identification of internalizing human single-chain antibodies targeting brain tumor sphere cells.
Zhu X; Bidlingmaier S; Hashizume R; James CD; Berger MS; Liu B
Mol Cancer Ther; 2010 Jul; 9(7):2131-41. PubMed ID: 20587664
[TBL] [Abstract] [Full Text] [Related]
20. Oxygen-dependent regulation of ndrg1 in human glioblastoma cells in vitro and in vivo.
Said HM; Stein S; Hagemann C; Polat B; Staab A; Anacker J; Schoemig B; Theobald M; Flentje M; Vordermark D
Oncol Rep; 2009 Jan; 21(1):237-46. PubMed ID: 19082468
[TBL] [Abstract] [Full Text] [Related]
[Next]